| Tivozanib studied in …STUDIED_INderived31 of 31show fewer |
|---|
| → studied in | NCT04645160Phase 1/Phase 2 · recruiting Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers · 31 trials list this drug (5 active) | — | — | Bile Duct Neoplasm,Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661720Phase 3 · recruiting Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · 31 trials list this drug (5 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma,Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05000294Phase 1/Phase 2 · recruiting Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types · 31 trials list this drug (5 active) | — | — | Malignant Breast Neoplasm,Neuroendocrine Tumor,Soft Tissue Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01885949Phase 2 · terminated Tivozanib + Enzalutamide in Adv Prostate Cancer · 31 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06053658Phase 2 · recruiting Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04987203Phase 3 · completed Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218692Phase 2 · not yet recruiting RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · 31 trials list this drug (5 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627963Phase 3 · completed A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970616Phase 1/Phase 2 · terminated A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma · 31 trials list this drug (5 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01769885NA · withdrawn Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03136627Phase 1/Phase 2 · completed Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01853644Phase 2 · completed Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer · 31 trials list this drug (5 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835223Phase 1/Phase 2 · completed Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery · 31 trials list this drug (5 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01297244Phase 2 · completed A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01673386Phase 2 · terminated A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01745367Phase 2 · terminated Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer · 31 trials list this drug (5 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076010Phase 3 · completed An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301). · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00502307Phase 2 · completed A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01369433NA · terminated A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols · 31 trials list this drug (5 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01030783Phase 3 · completed A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01782313Phase 2 · completed A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas · 31 trials list this drug (5 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01846871Phase 2 · completed Tivozanib for Recurrent Glioblastoma · 31 trials list this drug (5 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01972516Phase 2 · terminated Tivozanib As Maintenance Therapy In GYN · 31 trials list this drug (5 active) | — | — | Primary Peritoneal Carcinoma,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01058655Phase 1/Phase 2 · completed RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer · 31 trials list this drug (5 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00970411Phase 1 · completed Study of KRN951 in Patients With Solid Tumors · 31 trials list this drug (5 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807156Phase 2 · terminated Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer · 31 trials list this drug (5 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01478594Phase 2 · completed A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy · 31 trials list this drug (5 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728181Phase 1/Phase 2 · withdrawn A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation · 31 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01834183Phase 2 · withdrawn Tivozanib + Gemcitabine in Metastatic RCC · 31 trials list this drug (5 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00826878Phase 1 · completed An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) · 31 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01210846Phase 1 · completed A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors · 31 trials list this drug (5 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |